Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Sectors  >  Healthcare

News : Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors
04:39pREPLIGEN CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
04:39pHERON THERAPEUTICS, INC. (NASDAQ : HRTX) Files An 8-K Submission of Matters to a Vote of Security Holders
AQ
04:36pDARIOHEALTH SIGNS NEW FUNCTIONAL MEDICINE CLINIC TO ITS DIGITAL DIABETES PLATFORM : DarioHealth Corp.
AQ
04:36pAVENUE THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
04:33pPATENT ISSUED FOR ARRAYS OF INTEGRATED ANALYTICAL DEVICES AND METHODS FOR PRODUCTION (USPTO 10,310,178) : Pacific Biosciences of California Inc.
AQ
04:32pEVOKE PHARMA INC : Change in Directors or Principal Officers (form 8-K)
AQ
04:31pZIMMER BIOMET : Announces Chief Financial Officer Transition Plan
PR
04:30pNext Green Wave Announces CAD $3 Million Common Share Offering by Private Placement
NE
04:29pRESEARCHERS SUBMIT PATENT APPLICATION, “VACUUM PUMPING SYSTEM PROVIDED WITH A SOUNDPROOFING ARRANGEMENT”, FOR APPROVAL (USPTO 20190162187) : Agilent Technologies Inc.
AQ
04:27pNEXT GREEN WAVE : Announces CAD $3 Million Common Share Offering by Private Placement
AQ
04:24pBIOLIFE : Join our biopreservation best practices webinar!
PU
04:23pAVINGER INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
04:23pROCKET PHARMACEUTICALS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
AQ
04:23pGLAUKOS CORP : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
04:23pBELLICUM PHARMACEUTICALS, INC : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
Discover
06:36pROCHE : Mexican restaurant, Hungry Coyote, still not open in Needham
AQ
06:19pTETRA BIO-PHARMA INC : . Announces Proposed Offering of Units
AQ
06:18pCronos Group Inc. Announces Results of Vote for Election of Directors
GL
06:08pSCHOLAR ROCK : Announces Pricing of Public Offering of Common Stock
AQ
06:07pCANOPY GROWTH : shareholders approve proposed acquisition of Acreage Holdings
AQ
06:01pQUIDEL : Receives 510(k) Clearance for Quidel Triage® TOX Drug Screen, 94600 Toxicology Test for Use With Quidel's Triage® MeterPro Instrumented System
BU
05:57pPATENT APPLICATION TITLED “GRASPING TREATMENT INSTRUMENT” PUBLISHED ONLINE (USPTO 20190159801) : Olympus Corporation
AQ
05:52pSEDANA MEDICAL ENTERS CHINA - SIGNS WITH CHINESE DISTRIBUTOR : Sedana Medical
AQ
05:42pFINDINGS FROM GLAXOSMITHKLINE PLC PROVIDES NEW DATA ON BIOPHARMACEUTICALS (THE BIODISTRIBUTION AND CLEARANCE OF ALBUDAB, A NOVEL BIOPHARMACEUTICAL MEDICINE PLATFORM, ASSESSED VIA PET IMAGING IN HUMANS) : Drugs and Therapies - Biopharmaceuticals
AQ
05:41pAN APPLICATION FOR THE TRADEMARK “PURINETHOL ACCESSPROGRAM (MERCAPTOPURINE)” HAS BEEN FILED BY TEVA PHARMACEUTICALS USA : Teva Pharmaceuticals USA
AQ
05:41pFINDINGS FROM HEBEI MEDICAL UNIVERSITY UPDATE UNDERSTANDING OF MOLECULAR MEDICINE (KETAMINE DESTABILIZES GROWTH OF DENDRITIC SPINES IN DEVELOPING HIPPOCAMPAL NEURONS IN VITRO VIA A RHO-DEPENDENT MECHANISM) : Health and Medicine - Molecular Medicine
AQ
05:40pPATENT APPLICATION TITLED “INTRAOCULAR LENS STORAGE CART AND METHODS” PUBLISHED ONLINE (USPTO 20190164112) : Novartis AG
AQ
05:36p“TRANSDERMAL DRUG DELIVERY APPARATUS AND METHODS” IN PATENT APPLICATION APPROVAL PROCESS (USPTO 20190160273) : Sorrento Therapeutics Inc.
AQ
05:36pUPDATE ON OCULOPHARYNGEAL MUSCULAR DYSTROPHY PROGRAM : Benitec Biopharma Limited
AQ
05:35pRECENT FINDINGS FROM NOVARTIS PHARMA AG PROVIDES NEW INSIGHTS INTO BIOSIMILARS (THE ASSESSMENT OF QUALITY ATTRIBUTES FOR BIOSIMILARS : a Statistical Perspective On Current Practice and a Proposal): Drugs and Therapies - Biosimilars
AQ
05:23pREGENERON PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05:23pALIMERA SCIENCES INC : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
AQ
05:23pRESTORATION ROBOTICS, INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
05:20pPATENT ISSUED FOR PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM (USPTO 10,307,484) : Axsome Therapeutics Inc.
AQ
05:19pCANOPY GROWTH : announces shareholder approval in connection with the proposed acquisition of Acreage & provides update on American hemp and CBD operations
AQ
05:19pROCKWELL MEDICAL, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
05:19pBIOCEPT INC : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
AQ
05:19pSESEN BIO, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
05:19pENSIGN GROUP, INC : Other Events (form 8-K)
AQ
05:16pMUSTANG BIO, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05:13pAERPIO PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05:11pADIAL PHARMACEUTICALS, INC. : Shareholder Director Nominations, Other Events (form 8-K)
AQ
05:08pPATENT ISSUED FOR PROCESS FOR THE PREPARATION OF LORCASERIN HYDROCHLORIDE (USPTO 10,308,611) : Aurobindo Pharma Ltd.
AQ
05:07pCANNABIS APPROVAL RATINGS ARE ONLY INCREASING IN NORTH AMERICA AGAIN : FinancialNewsMedia.com
AQ
05:06pPATENT ISSUED FOR HYDROPHILIC IMPRESSION MATERIAL WITH IMPROVED STORAGE STABILITY (USPTO 10,307,345) : Dentsply Sirona Inc.
AQ
05:05pACERUS REACHES MUTUAL AGREEMENT WITH INNOVUS PHARMA TO TERMINATE DISTRIBUTION AND LICENSE AGREEMENT FOR URIVARX® IN CANADA : Acerus Pharmaceuticals Corporation
AQ
05:05pOSMOTICA PHARMACEUTICALS PLC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05:04pMIDATECH PHARMA : Description Report of Foreign Issuer
PU
05:03pHEDGEPATH PHARMACEUTICALS, INC. : Other Events (form 8-K)
AQ
05:03pDAVITA INC. : Completion of Acquisition or Disposition of Assets (form 8-K)
AQ
05:03pZIMMER BIOMET HOLDINGS, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
05:01pPATENT ISSUED FOR CONTROL CIRCUIT AND CONTROL METHOD FOR A SYNCHRONOUS MACHINE (USPTO 10,312,840) : Dentsply Sirona Inc.
AQ
04:58pAN APPLICATION FOR THE TRADEMARK “THERMOFLEX” HAS BEEN FILED BY THERMO FISHER SCIENTIFIC : Thermo Fisher Scientific
AQ
04:56pATLAS-PEDS : An Open-label, Multinational Study of Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B: DNA Viruses - Hepatitis B Virus
AQ
04:56pBLUEPRINT MEDICINES' HIGHLY SELECTIVE RET INHIBITOR BLU-667 SHOWS DURABLE ANTI-TUMOR ACTIVITY IN PATIENTS WITH RET-ALTERED CANCERS IN UPDATED ARROW TRIAL DATA PRESENTED AT ASCO 2019 : Blueprint Medicines
AQ
04:56pCALITHERA BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
04:56pOPTUM : Completes Acquisition of DaVita Medical Group from DaVita
BU
04:48pX4 PHARMACEUTICALS, INC : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
AQ
04:48pLIVANOVA : Welcomes Stacy Enxing Seng to Board of Directors
BU
04:46pNEW CHEMOTHERAPY STUDY RESULTS FROM BRISTOL-MYERS SQUIBB COMPANY DESCRIBED (EXTRACTING DATA FROM A CHEMOTHERAPY PRESCRIPTION PLATFORM FOR REAL-WORLD ONCOLOGY RESEARCH IN THE UK : a pilot study): Drugs and Therapies - Chemotherapy
AQ
04:46pSTUDY FINDINGS FROM APPLIED GENETIC TECHNOLOGIES CORPORATION PROVIDE NEW INSIGHTS INTO GENE THERAPY (TOXICOLOGY AND PHARMACOLOGY OF AN AAV VECTOR EXPRESSING CODON-OPTIMIZED RPGR IN RPGR-DEFICIENT RD9 MICE) : Biotechnology - Gene Therapy
AQ
04:45pINVACARE CORP : Regulation FD Disclosure (form 8-K)
AQ
04:44pNORDIC NANOVECTOR : European Patent Granted for Betalutin® or Humalutin® in Combination With Anti-CD20 Antibodies for Treating NHL: Nordic Nanovector
AQ
04:44pRESHAPE LIFESCIENCES INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
04:41pROSA TOTAL KNEE INVESTIGATIONAL TESTING AUTHORIZATION STUDY : PROSPECTIVE SINGLE CENTER STUDY OF THE ROSA Total Knee System: Surgery - Arthroplasty
AQ
07:36pBOSTON SCIENTIFIC : FDA panel sees link between paclitaxel devices, patient death risk
AQ
07:31pVIDEO — 48NORTH CO-CEO : Perks of Outdoor Growing
AQ
07:08pHEALTH MANAGEMENT INTERNATIONAL : Jennifer Johengen-Vogel promoted at BlueCross BlueShield of Western New York
AQ
06:59pPROMETIC LIFE SCIENCES : Announces Voting Results of its 2019 AGM
AQ
06:57pCANOPY GROWTH : Rivers to Report Fourth Quarter and Fiscal Year 2019 Financial Results
PR
1  2  3  4  5  6  7  8  9  10Next
Advertisement